Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1314)
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$536.26
Total Value
$986.71K
Shares Held After
45,173
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$535.05
Total Value
$388.98K
Shares Held After
47,013
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,076
Price
$534.14
Total Value
$574.74K
Shares Held After
47,740
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
667
Price
$533.16
Total Value
$355.62K
Shares Held After
48,816
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$532.24
Total Value
$211.30K
Shares Held After
49,483
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$531.21
Total Value
$70.65K
Shares Held After
49,880
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$25.65
Total Value
$10.70K
Shares Held After
76,140
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
45
Price
$533.51
Total Value
$24.01K
Shares Held After
125
% of Holdings
26.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
708
Price
$6.74
Total Value
$4.77K
Shares Held After
9,099
% of Holdings
7.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,766
Price
$13.92
Total Value
$108.07K
Shares Held After
232,699
% of Holdings
3.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
15,534
Price
$14.00
Total Value
$217.48K
Shares Held After
240,465
% of Holdings
6.1%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,767
Price
$13.92
Total Value
$108.09K
Shares Held After
255,999
% of Holdings
2.9%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
64,768
Price
$28.21
Total Value
$1.83M
Shares Held After
62,085
% of Holdings
51.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.41
Total Value
$255.59K
Shares Held After
503,596
% of Holdings
3.6%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
41,861
Price
$28.68
Total Value
$1.20M
Shares Held After
15,804
% of Holdings
72.6%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
3,961
Price
$37.77
Total Value
$149.61K
Shares Held After
112,018
% of Holdings
3.4%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
5,950
Price
$37.11
Total Value
$220.80K
Shares Held After
115,979
% of Holdings
4.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
9,440
Price
$72.77
Total Value
$686.90K
Shares Held After
92,832
% of Holdings
9.2%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
205,608
Price
$72.38
Total Value
$14.88M
Shares Held After
102,272
% of Holdings
66.8%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
450,000
Price
$5.00
Total Value
$2.25M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
8,785
Price
$37.77
Total Value
$331.81K
Shares Held After
404,778
% of Holdings
2.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
13,196
Price
$37.11
Total Value
$489.70K
Shares Held After
413,563
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
4,241
Price
$37.77
Total Value
$160.18K
Shares Held After
137,101
% of Holdings
3.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
6,371
Price
$37.11
Total Value
$236.43K
Shares Held After
141,342
% of Holdings
4.3%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$5.84
Total Value
$243.33K
Shares Held After
1,816,448
% of Holdings
2.2%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$28.09
Total Value
$280.86K
Shares Held After
105,211
% of Holdings
8.7%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
4,835
Price
$2.47
Total Value
$11.94K
Shares Held After
198,205
% of Holdings
2.4%
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
47,763
Price
$2.47
Total Value
$117.97K
Shares Held After
5,150,599
% of Holdings
0.9%
Opus Genetics, Inc. (IRD)
Jayagopal Ashwath — Chief Scientific & Dev. Ofc.
Shares
3,719
Price
$5.12
Total Value
$19.05K
Shares Held After
516,775
% of Holdings
0.7%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
3,719
Price
$5.25
Total Value
$19.53K
Shares Held After
300,781
% of Holdings
1.2%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
25,492
Price
$16.15
Total Value
$411.61K
Shares Held After
3,622
% of Holdings
87.6%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
24,438
Price
$5.21
Total Value
$127.33K
Shares Held After
1,750,855
% of Holdings
1.4%
BIOCRYST PHARMACEUTICALS INC (BCRX)
Barnes Alane P — Chief Legal Officer
Shares
150,000
Price
$9.15
Total Value
$1.37M
Shares Held After
400,703
% of Holdings
27.2%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
493
Price
$69.75
Total Value
$34.39K
Shares Held After
116,332
% of Holdings
0.4%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
8,378
Price
$69.03
Total Value
$578.33K
Shares Held After
116,825
% of Holdings
6.7%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
3,629
Price
$68.09
Total Value
$247.10K
Shares Held After
125,203
% of Holdings
2.8%
Opus Genetics, Inc. (IRD)
Zaremba Rabourn Amy — Head of Fin. Quality Assurance
Shares
2,816
Price
$5.25
Total Value
$14.77K
Shares Held After
190,312
% of Holdings
1.5%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$15.16
Total Value
$90.96K
Shares Held After
2,112,777
% of Holdings
0.3%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$15.16
Total Value
$227.40K
Shares Held After
2,118,777
% of Holdings
0.7%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$41.30
Total Value
$30.27K
Shares Held After
31,767
% of Holdings
2.3%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
72,276
% of Holdings
2.4%
Showing 201–250 of 1314 transactions (page 5 of 27)